UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Birth prevalence of disorders detectable through newborn screening by race/ethnicity

Genetics in medicine, 2012-11, Vol.14 (11), p.937-945

2012

Volltextzugriff (PDF)

Defining Sickle Cell Disease Mortality Using a Population-Based Surveillance System, 2004 through 2008

Public health reports (1974), 2016-03, Vol.131 (2), p.367-375

2016

Volltextzugriff (PDF)

Emergency department utilization by Californians with sickle cell disease, 2005–2014

Pediatric blood & cancer, 2017-06, Vol.64 (6), p.np-n/a

2017

Volltextzugriff (PDF)

Adrenoleukodystrophy Newborn Screening in California Since 2016: Programmatic Outcomes and Follow-Up

International journal of neonatal screening, 2021-04, Vol.7 (2), p.22

2021

Volltextzugriff (PDF)

Population based surveillance in sickle cell disease: Methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH)

Pediatric blood & cancer, 2014-12, Vol.61 (12), p.2271-2276

2014

Volltextzugriff (PDF)

The First Year Experience of Newborn Screening for Pompe Disease in California

International journal of neonatal screening, 2020-03, Vol.6 (1), p.9-9

2020

Volltextzugriff (PDF)

Fred Lorey Passed Away

International journal of neonatal screening, 2020-11, Vol.6 (4), p.87

2020

Volltextzugriff (PDF)

Infants suspected to have very-long chain acyl-CoA dehydrogenase deficiency from newborn screening

Molecular genetics and metabolism, 2014-04, Vol.111 (4), p.484-492

2014

Volltextzugriff (PDF)

Follow-up status during the first 5 years of life for metabolic disorders on the federal Recommended Uniform Screening Panel

Genetics in medicine, 2018-08, Vol.20 (8), p.831-839

2018

Volltextzugriff (PDF)

Newborn Screening for Cystic Fibrosis in California

Pediatrics (Evanston), 2015-12, Vol.136 (6), p.1062

2015

Volltextzugriff (PDF)

Newborn Screening for Severe Combined Immunodeficiency and T-cell Lymphopenia in California, 2010-2017

Pediatrics (Evanston), 2019-02, Vol.143 (2)

2019

Volltextzugriff (PDF)

First Three Years’ Experience of Mucopolysaccharidosis Type I Newborn Screening in California

The Journal of pediatrics, 2023-12, Vol.263, p.113644, Article 113644

2023

Volltextzugriff (PDF)

The newborn screening educational gap: What prenatal care providers do compared with what is expected

American journal of obstetrics and gynecology, 2006, Vol.194 (1), p.131-137

2006

Volltextzugriff (PDF)

Genomic sequencing in cystic fibrosis newborn screening: what works best, two-tier predefined CFTR mutation panels or second-tier CFTR panel followed by third-tier sequencing?

Genetics in medicine, 2017-10, Vol.19 (10), p.1159-1163

2017

Volltextzugriff (PDF)

Episodic Patterns of High Emergency Department Utilization Among Sickle Cell Disease Patients

Blood, 2016-12, Vol.128 (22), p.316-316

2016

Volltextzugriff (PDF)

The First Year Experience of Newborn Screening for Pompe Disease in California

International journal of neonatal screening, 2020-03, Vol.6 (1)

2020

Volltextzugriff (PDF)

Providers' Perspectives on Treating Patients With Thalassemia

Journal of pediatric hematology/oncology, 2019-10, Vol.41 (7), p.e421

2019

Volltextzugriff (PDF)

Damaged goods?: an empirical cohort study of blood specimens collected 12 to 23 hours after birth in newborn screening in California

Genetics in medicine, 2016-03, Vol.18 (3), p.259-264

2016

Volltextzugriff (PDF)

Economic evaluation of tandem mass spectrometry screening in California

Pediatrics (Evanston), 2006-05, Vol.117 (5 Pt 2), p.S280

2006

Volltextzugriff (PDF)

Impact of Immigration and Migration on Thalassemia Surveillance in California, 2004-2008

Blood, 2014-12, Vol.124 (21), p.4855-4855

2014

Volltextzugriff (PDF)

The context and approach for the California newborn screening short- and long-term follow-up data system: Preliminary findings

Genetics in medicine, 2010-12, Vol.12 (12 Suppl), p.S242-S250

2010

Volltextzugriff (PDF)

State-based surveillance for selected hemoglobinopathies

Genetics in medicine, 2015-02, Vol.17 (2), p.125-130

2015

Volltextzugriff (PDF)

Biochemical, molecular, and clinical characteristics of children with short chain acyl-CoA dehydrogenase deficiency detected by newborn screening in California

Molecular genetics and metabolism, 2012-05, Vol.106 (1), p.55-61

2012

Volltextzugriff (PDF)

California’s experience with SMA newborn screening: A successful path to early intervention

Journal of neuromuscular diseases, 2022-01, Vol.9 (6), p.777-785

2022

Volltextzugriff (PDF)

A framework for assessing outcomes from newborn screening: on the road to measuring its promise

Molecular genetics and metabolism, 2016-08, Vol.118 (4), p.221-229

2016

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(43)
Dissertationen
(1)

Sprache

Englisch
(44)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Birth prevalence of disorders detectable through newborn screening by race/ethnicity

Defining Sickle Cell Disease Mortality Using a Population-Based Surveillance System, 2004 through 2008

Emergency department utilization by Californians with sickle cell disease, 2005–2014

Adrenoleukodystrophy Newborn Screening in California Since 2016: Programmatic Outcomes and Follow-Up

Population based surveillance in sickle cell disease: Methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH)

The First Year Experience of Newborn Screening for Pompe Disease in California

Fred Lorey Passed Away

Infants suspected to have very-long chain acyl-CoA dehydrogenase deficiency from newborn screening

Follow-up status during the first 5 years of life for metabolic disorders on the federal Recommended Uniform Screening Panel

Newborn Screening for Cystic Fibrosis in California

Newborn Screening for Severe Combined Immunodeficiency and T-cell Lymphopenia in California, 2010-2017

First Three Years’ Experience of Mucopolysaccharidosis Type I Newborn Screening in California

The newborn screening educational gap: What prenatal care providers do compared with what is expected

Genomic sequencing in cystic fibrosis newborn screening: what works best, two-tier predefined CFTR mutation panels or second-tier CFTR panel followed by third-tier sequencing?

Episodic Patterns of High Emergency Department Utilization Among Sickle Cell Disease Patients

The First Year Experience of Newborn Screening for Pompe Disease in California

Providers' Perspectives on Treating Patients With Thalassemia

Damaged goods?: an empirical cohort study of blood specimens collected 12 to 23 hours after birth in newborn screening in California

Economic evaluation of tandem mass spectrometry screening in California

Impact of Immigration and Migration on Thalassemia Surveillance in California, 2004-2008

The context and approach for the California newborn screening short- and long-term follow-up data system: Preliminary findings

State-based surveillance for selected hemoglobinopathies

Biochemical, molecular, and clinical characteristics of children with short chain acyl-CoA dehydrogenase deficiency detected by newborn screening in California

California’s experience with SMA newborn screening: A successful path to early intervention

A framework for assessing outcomes from newborn screening: on the road to measuring its promise

Suchergebnisse filtern